Positions
- Associate Professor, Internal Medicine, Brody School of Medicine
- Contact Info
Co-author Network
Map of Science
Co-investigator Network
Ogugua Ndili Obi
Affiliation
Publications
selected publications
presentations
-
presentation
- "Quality of Life in Sarcoidosis: Seen and Unseen management options". Faculty lecture and expert panel participant at the CHEST 2023 National conference. Honolulu HI, October 11, 2023., CHEST 2023
-
Cardiac Sarcoidosis: The Beat NOT to be Missed
October 19, 2022
, CHEST 2022 Annual Meeting 2022 - Overview of Sarcoidosis with an Emphasis on Recent Updates, 2019 NC Thoracic Society Annual Education Conference 2019
- Update on Sarcoidosis - Invited Guest Lecture to the NC Thoracic Society's Annual Educational Conference, Invited Guest Lecture to the NC Thoracic Society's Annual Educational Conference 2019
- Sarcoidosis in the South Eastern USA, South Eastern Sarcoid Consortium (SESCo) 2019
- Role of Baseline Dyspnea Index (BDI) and Transition Dyspnea Index (TDI) as a measure of self-reported Health related Quality of Life in Sarcoidosis Patients, American Thoracic Society (ATS) 2019 International Conference 2019
- Building a Sarcoidosis Database, Americas Association of Sarcoidosis and Other Granulomatous Diseases (AASOG) 2019
- Updates in Sarcoidosis - Internal Medicine Grand Rounds, Grand Rounds - Internal Medicine 2019
- Establishing The East Carolina University Sarcoidosis Registry (ECUSaR) - A work in Progress, ECU Department of Public Health Research Presentations 2018
Research
principal investigator on
- A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis awarded by Priovant Therapeutics Inc 2025
- A Randomized, Double-blind, Placebo-controlled Phase 2 Study with Open-label Extension to Assess the Efficacy and Safety of Namilumab in Subjects with Chronic Pulmonary Sarcoidosis. awarded by Labcorp Drug Development, Inc (formerly Covance, Inc.) 2022 - 2025
- XTMAB-16-201: A seamless, Phase 1b/2 multiple ascending dose/proof of concept study of XTMAB-16 in patients with pulmonary sarcoidosis with or without extrapulmonary manifestations awarded by Pharmaceutical Research Associates Inc 2023 - 2025
- XTMAB-16-202: A Long-term Multicenter Open-label Study to Evaluate the Long-term Safety and Durability of Effect of XTMAB-16 in Patients With Pulmonary Sarcoidosis With or Without Extra-pulmonary Involvement awarded by Pharmaceutical Research Associates Inc 2023 - 2025
- ATYR1923-C-004: A Phase 3, Randomized, Double-Blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Intravenous Efzofitimod in Patients with Pulmonary Sarcoidosis awarded by aTyr Pharma Inc 2022 - 2025
- A subject and investigator blinded, randomized, placebo controlled,repeat-dose, multicenter study to investigate efficacy, safety, and tolerability of CMK389 in patients with chronic pulmonary sarcoidosis awarded by Novartis Pharmaceuticals Corporation 2021 - 2024
- Registry for Advanced Sarcoidosis (ReAS) awarded by University of Cincinnati (UC) 2019 - 2022
- A Randomized, Double-Blind, Placebo-Controlled Multiple Ascending Dose Study of Intravenous ATYR1923 in Patients with Pulmonary Sarcoidosis awarded by aTyr Pharma Inc 2019 - 2022
- Features and outcomes of viral infections in sarcoidosis and other Interstitial Lung diseases (ILDs): A prospective study during a pandemic awarded by University of Pennsylvania 2019
- Sarcoidosis Around the World awarded by University of Cincinnati 2019
- Validation of a Sarcoidosis Diagnostic Score (SDS) awarded by University of Cincinatti 2018
investigator on
- Registry of Sarcoidosis Associated Pulmonary Hypertension (ReSAPH) awarded by University of Cincinnati (UC) 2020 - 2022
Service
professional service activities
- AASOG Junior Faculty Committee Member ;AASOG Junior Faculty Committee. ;AASOG is as an organizational satellite in the Americas to the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG). 2018
Background
education and training
- M.S. in Epidemiology, Harvard School of Public Health
- MPH in Quantitative & Research Methods/ International Health, Harvard School of Public Health
credentials
awards and honors
Contact
preferred title
- Director, Medical Intensive Care Unit, Vidant Medical Center, Greenville, NC